ClinVar Miner

Submissions for variant NM_018941.3(CLN8):c.779C>T (p.Pro260Leu) (rs146579299)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000187129 SCV000240705 uncertain significance not provided 2018-09-14 criteria provided, single submitter clinical testing A variant of uncertain significance has been identified in the CLN8 gene. The P260L variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The P260L variant is observed in 64/24030 (0.3%) alleles from individuals of African background in large population cohorts (Lek et al., 2016). The P260L variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. Missense variants in nearby residues have been reported in the Human Gene Mutation Database in individuals with neuronal ceroid lipofuscinosis (Stenson et al., 2014). Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.
Invitae RCV001080174 SCV000628996 likely benign Neuronal ceroid lipofuscinosis 2019-12-31 criteria provided, single submitter clinical testing
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago RCV000768188 SCV000898619 uncertain significance Ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant; Neuronal ceroid lipofuscinosis 8 2017-09-29 criteria provided, single submitter clinical testing CLN8 NM_018941.3 exon 3 p.Pro260Leu (c.779C>T): This variant has not been reported in the literature but is present in 64/24030 African individuals in the Genome Aggregation Database ( This variant is present in ClinVar (Variation ID:205196). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain.
Natera, Inc. RCV001272624 SCV001454744 uncertain significance Neuronal ceroid lipofuscinosis 8 2020-06-25 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.